Lack of synergy of erythromycin combined with penicillin or cefotaxime against Streptococcus pneumoniae in vitro

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 3, 2003, Pages 1151-1153

  Lin, Eugene ^a,b   Stanek, Ronald J ^a   Mufson, Maurice A ^a  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFOTAXIME; ERYTHROMYCIN; MACROLIDE; PENICILLIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; COLONY FORMING UNIT; DRUG EFFECT; DRUG POTENTIATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; CEFOTAXIME; CEPHALOSPORINS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ERYTHROMYCIN; KINETICS; MICROBIAL SENSITIVITY TESTS; PENICILLINS; STREPTOCOCCUS PNEUMONIAE; TIME FACTORS;

EID: 0037417017     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.3.1151-1153.2003     Document Type: Article

References (13)

1. Amsden, G. W. 1999. Pneumococcal macrolide resistance - myth or reality? J. Antimicrob. Chemother. 44:1-6.
2. Bajaksouzian, S., M. A. Visalli, M. R. Jacobs, and P. C. Appelbaum. 1996. Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods. Antimicrob. Agents Chemother. 40:1973-1976.
3. Bartlett, J. G., R. F. Breiman, L. A. Mandell, and T. M. File, Jr. 1998. Community-acquired pneumonia in adults: guidelines for management. Clin. Infect. Dis. 26:811-838.
4. Friedland, I. R., M. Paris, S. Shelton, and G. H. McCracken. 1994. Time-kill studies of antibiotic combinations against penicillin-resistant and -susceptible Streptococcus pneumoniae. J. Antimicrob. Chemother. 34:231-237.
5. Gross, M. E., K. P. Giron, J. D. Septimus, E. O. Mason, Jr., and D. M. Musher. 1995. Antimicrobial activities of beta-lactam antibiotics and gentamicin against penicillin-susceptible and penicillin-resistant pneumococci. Antimicrob. Agents Chemother. 39:1166-1168.
6. Johansen, H. K., T. G. Jensen, R. B. Dessau, B. Lundgren, and N. Frimodt-Moller. 2000. Antagonism between penicillin and erythromycin against Streptococcuspneumoniae in vitro and in vivo. J. Antimicrob. Chemother. 46:973-980.
7. Mufson, M. A., and R. J. Stanek. 1999. Bacteremic pneumococcal pneumonia in one American city: a 20-year longitudinal study, 1978-1997. Am. J. Med. 107:34S-43S.
8. National Committee for Clinical Laboratory Standards. 1997. Performance standards for antimicrobial disk susceptibility tests, 6th ed. Approved standard. National Committee for Clinical Laboratory Standards, Wayne, Pa.
9. Niederman, M. S., J. B. Bass, Jr., G. D. Campbell, A. M. Fein, R. F. Grossman, L. A. Mandell, T. J. Marrie, G. A. Sarosi, A. Torres, and V. L. Yu. 1993. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am. Rev. Respir. Dis. 148:1418-1426.
10. Niederman, M. S., L. A. Mandell, A. Anzueto, J. B. Bass, W. A. Broughton, G. D. Campbell, N. Dean, T. File, M. J. Fine, P. A. Gross, F. Martinez, T. J. Marrie, J. F. Plouffe, J. Ramirez, G. A. Sarosi, A. Torres, R. Wilson, and V. L. Yu. 2001. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am. J. Respir. Crit. Care Med. 163:1730-1754.
11. Saverino, D., E. A. Debbia, A. Pescue, A. M. Lepore, and G. C. Schito. 1992. Antibacterial profile of flurithromycin, a new macrolide. J. Antimicrob. Chemother. 30:261-272.
12. Stanek, R. J., and M. A. Mufson. 1995. Emergence of penicillin-resistant invasive pneumococci in a single American community. Am. J. Med. Sci. 310:150-155.
13. Waterer, G. W., G. W. Somes, and R. G. Wunderink. 2001. Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia. Arch. Intern. Med. 161:1837-1842.